Maspin (mammary serine protease inhibitor), a member of the serine protease inhibitor/non-inhibitor superfamily, has been shown to have tumor growth suppression activity in vitro and in vivo for a variety of cancers [24]. Here, SERPINB5 is linked to cancer.